Live feed
Filing
SC 13G
SC 13G0001193125-16-478450·Novartis Bioventures Ltd
Schedule 13G ownership disclosure
PROTEOSTASIS THERAPEUTICS, INC.
Security class unavailable · CUSIP: 74373B109
Event date: 2016-02-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.8050%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-16-478450
- Form type
- SC 13G
- Filer
- Novartis Bioventures Ltd
- CIK
- CIK 1297709
- Filed
- Feb 25, 2016
- Reporting period
- Feb 17, 2016
- Description
- Schedule 13G beneficial ownership